|
1
|
World Health Organisation (WHO), . Global
tuberculosis report. 2014.
|
|
2
|
Qadeer E, Fatima R, Fielding K, Qazi F,
Moore D and Khan MS: Good quality locally procured drugs can be as
effective as internationally quality assured drugs in treating
multi-drug resistant tuberculosis. PLoS One. 10:e01260992015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tiwari D, Tiwari RP, Chandra R, Bisen PS
and Haque S: Efficient ELISA for Diagnosis of Active Tuberculosis
Employing a Cocktail of Secretory Proteins of Mycobacterium
tuberculosis. Folia Biol (Praha). 60:10–20. 2014.PubMed/NCBI
|
|
4
|
Hajiabdolbaghi M, Rasoulinejad M, Davoudi
AR, Alikhani A and Najafi N: Application of peripheral blood
Mycobacterium tuberculosis PCR for diagnosis of tuberculosis
patients. Eur Rev Med Pharmacol Sci. 18:185–189. 2014.PubMed/NCBI
|
|
5
|
Chen Y, Deng Q, Zhan Z, Guo A, Xiang J,
Chen J, Zhou J, Zeng Q, Wei W, Tong Q, et al: Establishment of
human IFN-gamma in vitro release assay and its application in
tuberculosis diagnosis. Sheng Wu Gong Cheng Xue Bao. 24:1653–1657.
2008.(In Chinese). PubMed/NCBI
|
|
6
|
Bwanga F, Hoffner S, Haile M and Joloba
ML: Direct susceptibility testing for multi drug resistant
tuberculosis: A meta-analysis. BMC Infect Dis. 9:672009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ugarte-Gil CA, Elkington P, Gilman RH,
Coronel J, Tezera LB, Bernabe-Ortiz A, Gotuzzo E, Friedland JS and
Moore DA: Induced sputum MMP-1, −3 & −8 concentrations during
treatment of tuberculosis. PLoS One. 8:e613332013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sundararajan S, Babu S and Das SD:
Comparison of localized versus systemic levels of Matrix
metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and
cytokines in tuberculous and non-tuberculous pleuritis patients.
Hum Immunol. 73:985–991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang KE, Shon YJ, Cha BK, Park MJ, Chu
MS, Kim YJ, Jeong ET and Kim HR: Tissue inhibitor of
metalloproteinase-1 is responsible for residual pleural thickening
in pleural tuberculosis. Tohoku J Exp Med. 235:327–333. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Chao Y, Deng Q, Liu T, Xiang J,
Chen J, Zhou J, Zhan Z, Kuang Y, Cai H, et al: Potential challenges
to the Stop TB Plan for humans in China; cattle maintain M. bovis
and M. tuberculosis. Tuberculosis (Edinb). 89:95–100. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Li S, Luo Y, Chen Y, Cheng S,
Zhang G, Hu C, Chen H and Guo A: Mycobacterium bovis and BCG induce
different patterns of cytokine and chemokine production in
dendritic cells and differentiation patterns in CD4+ T cells.
Microbiology. 159:366–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fontán P, Aris V, Ghanny S, Soteropoulos P
and Smith I: Global transcriptional profile of Mycobacterium
tuberculosis during THP-1 human macrophage infection. Infect Immun.
76:717–725. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weglarz L, Molin I, Orchel A, Parfiniewicz
B and Dzierzewicz Z: Quantitative analysis of the level of p53 and
p21(WAF1) mRNA in human colon cancer HT-29 cells treated with
inositol hexaphosphate. Acta Biochim Pol. 53:349–356.
2006.PubMed/NCBI
|
|
14
|
Gall D and Nielsen K: Comparison of some
methods for determing cutoff values for serological assays: A
retrospective study using the fluorescence polarization assay. J
Immunoassay Immunochem. 22:85–98. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Small PM and Pai M: Tuberculosis
diagnosis-time for a game change. N Engl J Med. 363:1070–1071.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rand L, Green JA, Saraiva L, Friedland JS
and Elkington PT: Matrix metalloproteinase-1 is regulated in
tuberculosis by a p38 MAPK-dependent, p-aminosalicylic
acid-sensitive signaling cascade. J Immunol. 182:5865–5872. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Anand SP and Selvaraj P: Effect of 1, 25
dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and
the inhibitor TIMP-1 in pulmonary tuberculosis. Clin Immunol.
133:126–131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elkington P, Shiomi T, Breen R, Nuttall
RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F,
Lipman M, et al: MMP-1 drives immunopathology in human tuberculosis
and transgenic mice. J Clin Invest. 121:1827–1833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Walker NF, Clark SO, Oni T, Andreu N,
Tezera L, Singh S, Saraiva L, Pedersen B, Kelly DL, Tree JA, et al:
Doxycycline and HIV infection suppress tuberculosis-induced matrix
metalloproteinases. Am J Respir Crit Care Med. 185:989–997. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoheisel G, Sack U, Hui DS, Huse K, Chan
KS, Chan KK, Hartwig K, Schuster E, Scholz GH and Schauer J:
Occurrence of matrix metalloproteinases and tissue inhibitors of
metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb).
81:203–209. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tincati C, Iii AJ Cappione and
Snyder-Cappione JE: Distinguishing Latent from Active Mycobacterium
tuberculosis Infection Using Elispot Assays: Looking Beyond
Interferon-gamma. Cells. 1:89–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
